Management of Multiple Drug-Resistant Infections

  • Stephen H. Gillespie

Part of the Infectious Disease book series (ID)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Gram-Positive Bacteria

  3. Gram-Negative Pathogens

    1. Front Matter
      Pages 115-115
    2. Peter J. Jenks
      Pages 141-157
    3. Catherine A. Ison, Jonathan Ross
      Pages 159-172
    4. Andrew J. H. Simpson
      Pages 209-222
  4. Mycobacteria

    1. Front Matter
      Pages 223-223
    2. Paul D. van Helden, Robin M. Warren, Pieter Uys, Gian D. van der Spuy, Thomas C. Victor
      Pages 225-242
    3. Sanjay Bhagani, Marc Lipman
      Pages 243-256
  5. Fungal and Parasitic Infections

    1. Front Matter
      Pages 269-269
    2. Sanya Clements, Christopher C. Kibbler
      Pages 271-296
    3. Thean Yen Tan, Rosemary A. Barnes
      Pages 297-317
    4. Elizabeth Ashley, François Nosten
      Pages 319-339
    5. Michael J. Doenhoff, Katherine Wheatcroft-Francklow
      Pages 341-352
  6. Viral Infections

    1. Front Matter
      Pages 353-353
    2. Deenan Pillay
      Pages 355-378
    3. Vincent C. Emery, Mohammad Raza Naqvee, Anuradha Chawla
      Pages 379-391
  7. Back Matter
    Pages 393-403

About this book


Multiple drug resistance to antimicrobials is a growing problem that limits the effective lifetime of nearly all drugs developed against microorganisms. In Management of Multiple Drug-Resistant Infections, prominent clinicians and leading microbiologists describe how practicing physicians can best treat bacterial, viral, protozoal, and helminthic infections when there is significant resistance to antibiotics. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegaloviral agents is also discussed, as are those measures necessary to prevent the spread of infections among patients. When national or international treatment guidelines cannot be established, clinical trial data, in vitro susceptibility data, and epidemiologic and pharmacological evidence are cited to help make treatment decisions. Wherever possible, the question of drug resistance is set in the context of its biology and epidemiology.
Comprehensive and practice-oriented, Management of Multiple Drug-Resistant Infections offers physicians and clinical microbiologists treating infectious disease patients not only a critically evaluated guide to the immense literature of the field, but also an up-to-date practical survey of today's gold-standard therapeutic strategies.


HIV Malaria Parasitic Infections antibiotics bacteria infection infections viral infection

Editors and affiliations

  • Stephen H. Gillespie
    • 1
  1. 1.Department of Medical MicrobiologyRoyal Free and University College Medical SchoolLondonEngland

Bibliographic information